The Quebec cannabis society (SQDC) posted net earnings of $19 million for its second quarter on Friday, up 25.4 per cent from the same period last year, which it attributed in part to the expansion of its branch network. The Crown corporation's network consisted of 77 outlets at the end of the most recent quarter, 32 more than at the same time last year.

As a result, SQDC's sales totalled $142.0 million in the second quarter, up 18 per cent from $120.2 million a year earlier.

In addition to the growth in the number of branches, the SQDC attributed the increase in revenue to the migration of consumers from the illicit market.

The Valens Company (TSX:VLNS, OTCQX:VLNCF) President Jeff Fallows joined Steve Darling from Proactive to share news the company has signed a deal with Société québécoise du cannabis. Fallows telling this deal will now see Valens products distributed into Québec.

Fallows shared that this move for Valens is huge entering the third-largest cannabis market in Canada, representing approximately 15% of Canadian cannabis retail sales. Fallows also shared with Proactive the company’s 3rd quarter financial numbers that included 32.7 % rise in gross revenue and provincial listings increased by 37.1% to 181 at the end of September. Fallows also shared with Proactive, the company has signed a manufacturing agreement with Aurora Cannabis.

Drugs seized in the raids included GHB, cocaine, crack cocaine, cannabis candy, ecstasy, crystal meth, methamphetamine tablets, amphetamine tablets and other illicit drugs.

Navaya Inc., an innovative Quebec-based cannabis producer, today received from Health Canada its sales licence to sell dried cannabis products across Canada. The licence brings to fruition the goal set out by Navaya to deliver high yield, consistent quality cannabis, to all Canadians of legal age. The newly licensed producer will be launching its products this fall in Société québécoise du cannabis (SQDC) locations across the province of Quebec.

Valens Co. said Monday that it will enter the Quebec marketplace after signing a preliminary commitment with the provincial cannabis distributor there.

The Canadian manufacturer of cannabis products said that it executed a letter of intent with the Societe quebecoise du cannabis, a subsidiary of the government-owned Societe des alcools du Quebec, for the distribution of its cannabis products in the province.

The Good Shroom Co Inc has announced that its wholly-owned subsidiary and licensed cannabis processor, operating as Seul CBD, has been approved by the Société Quebecoise du Cannabis to sell the company’s Velada wellness beverage brand and Nordique Royale hash brand in the Canadian province of Quebec.  

Good Shroom said its cannabis products are expected to be available for purchase by consumers in Quebec by year’s end.

The company noted its Velada brand produces cannabis-infused instant coffee and teas in a variety of different flavours such as matcha latte, golden milk latte, hot chocolate, and café olé, which will become Canada's first cannabis-infused coffee. 

Quebec's Court of Appeal agreed with the Quebec Government's ban on home-grown cannabis. This reversed the previous Superior Court ruling in 2019 which said the Quebec Government's ban on home-grown cannabis was a violation of federal law.

"A provincial government that denies its citizens the right to grow their four federally legal cannabis plants is on a slippery slope to removing other personal freedoms," said Dr. Av Singh, one of TobaGrown's expert witnesses.

The outcome of Quebec's lawsuit will hold substantial weight in the similar case in Manitoba, where Jesse Lavoie started the "TobaGrown Movement" and filed a lawsuit against the Manitoba Government's ban on home-grown cannabis in August 2020.

A history of marijuana use among men and women is not associated with compromised effects on IVF (in vitro fertilization) outcomes, according to data published in the Journal of Cannabis Research.

A team of researchers from Canada and Israel assessed IVF treatment outcomes among male-female, non-donor IVF patients that were either cannabis users or non-users.

IntelGenx Corp. (TSX-V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today announced that it has completed an initial shipment of CBD Filmstrips in support of Heritage Cannabis Holdings Corp.’s (“Heritage Cannabis”) (CSE:CANN) Canadian market launch of its “CB4 Control” branded product.

The CBD Filmstrips were produced at IntelGenx’s manufacturing facility under Canadian GPP conditions and registered as a product for sale with Health Canada as a cannabis product governed by the Cannabis Act.